Akiri is specialised in searching and analysing scientific information. The company offers professional support for patent and literature search requests.

Akiri

MediBloc Limited is developing a patient-centered health data ecosystem that protects individual privacy and enhances the reliability of health data through a blockchain-based platform called ‘Panacea’.

MediBloc Limited

Medicalchain uses blockchain technology to securely manage health records, aiming to give patients control over their medical data and facilitate sharing within their medical network. The company self-describes its solution as collaborative and efficient for healthcare.

Metric
Company Name	Akiri	MediBloc Limited	Medicalchain
Symbol
MSH ID	SE:AKIRI	COM:MEDIBLOC	COM:MEDICALCHAIN
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Information Services	Health Technology	Health Information Technology
Country	SE	KR	FR
Stage		Venture Round	Initial Coin Offering
Employee Count
Website	akiri.se	medibloc.com	medicalchain.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			664
Web Traffic Growth			-0.79
Valuation
Raised Capital			24M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AKIR

SE:AKIRI

Akiri

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue